Get a reply from this employer
Your resume and cover letter, tailored to exactly what they’re hiring for.
Apnimed, a Boston-area biopharmaceutical company focused on sleep apnea, seeks a Sr. Director to build and run the commercial operations infrastructure—licensing, P2P programs, congresses and field meetings, content submission, and literature distribution.
You will lead cross‑functional partnerships to scale the business, identify AI and automations to reduce manual work, and position the organization for the potential commercialization of AD109, a first‑in‑class pharmaceutical treatment for
Apnimed is a rapidly growing pharmaceutical company working to transform the treatment of sleep apnea based on a simple idea - patients with obstructive sleep apnea (OSA) could benefit from treatment with a safe and effective oral medication dosed once daily at bedtime. Our lead development program, AD109, targets the neurologic control of upper airway muscles to maintain an open airway during sleep. Apnimed is committed to innovation, as well as state-of-the-art advancements in sleep medicine, which is leading to the development of a portfolio of novel pharmacologic therapies for sleep apnea and related disorders.
Recognized by the Boston Business Journal as one of the Best Places to Work in both 2024 and 2025, we are continuing to grow and build the foundational operations that enable our employees and our mission to thrive.
The Sr. Director, Commercial Infrastructure & Operations reports to the VP, Commercial Operations and is responsible for the operational infrastructure and logistics that keep Apnimed's commercial organization running day to day, spanning field state licensing, peer-to-peer (P2P) program operations, congresses and field meetings, commercial content submission, and sample and literature operations. The successful candidate will also play a key role in identifying where AI and automation can meaningfully reduce manual work and improve accuracy across these programs. This is an exciting opportunity to build durable, well-run commercial infrastructure right the first time and shape how it runs for years to come as Apnimed prepares for the potential commercialization of AD109, an investigational therapy, and to be at the forefront of a major paradigm shift in the treatment of sleep apnea from medical devices and surgery to a first in class pharmaceutical treatment.
The expected annual base salary range for this role is $270,000.00 to $294,000.00. Final compensation will depend on the selected candidate's level, education and relevant experience.
Apnimed is a rapidly growing pharmaceutical company working to transform the treatment of sleep apnea based on a simple idea - patients with obstructive sleep apnea (OSA) could benefit from treatment with a safe and effective oral medication dosed once daily at bedtime. Our lead development program, AD109, targets the neurologic control of upper airway muscles to maintain an open airway during sleep. Apnimed is committed to innovation, as well as state-of-the-art advancements in sleep medicine, which is leading to the development of a portfolio of novel pharmacologic therapies for sleep apnea and related disorders.
Recognized by the Boston Business Journal as one of the Best Places to Work in both 2024 and 2025, we are continuing to grow and build the foundational operations that enable our employees and our mission to thrive.
The Sr. Director, Commercial Infrastructure & Operations reports to the VP, Commercial Operations and is responsible for the operational infrastructure and logistics that keep Apnimed's commercial organization running day to day, spanning field state licensing, peer-to-peer (P2P) program operations, congresses and field meetings, commercial content submission, and sample and literature operations. The successful candidate will also play a key role in identifying where AI and automation can meaningfully reduce manual work and improve accuracy across these programs. This is an exciting opportunity to build durable, well-run commercial infrastructure right the first time and shape how it runs for years to come as Apnimed prepares for the potential commercialization of AD109, an investigational therapy, and to be at the forefront of a major paradigm shift in the treatment of sleep apnea from medical devices and surgery to a first in class pharmaceutical treatment.
The expected annual base salary range for this role is $270,000.00 to $294,000.00. Final compensation will depend on the selected candidate's level, education and relevant experience.